2 ASX penny stocks to consider buying while their prices are this cheap

Analysts think high rewards could be on offer from these high risk stocks.

| More on:
a man looks down at his phone with a look of happy surprise on his face as though he is thrilled with good news.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors with a high risk tolerance might want to consider adding the two ASX penny stocks in this article to a balanced portfolio.

That's because although they are high risk investments, they have the potential to offer high rewards.

Let's take a closer look at them and see why analysts are tipping them as buys right now:

Pointsbet Holdings Ltd (ASX: PBH)

This sports betting company has been given the thumbs up by analysts at Bell Potter.

It thinks Pointsbet could be an ASX penny stock to buy based on its current valuation. The broker feels that the market is undervaluing its operations and sees it as a potential takeover target for a bigger player. It explains:

We determine our price target for PointsBet through a sum-of-the-parts (SOTP) and there is no change in the $0.63 valuation. The components of this valuation are $150m for the Australian business ($0.46/share), $25m for the Canadian business ($0.08/share) and $30m in corporate cash ($0.09/share). We note we ascribe no value for the Banach technology which PointsBet can continue to use for in-play betting in Canada and, to a lesser extent, Australia. We also believe PointsBet is a potential takeover target given its market position (fifth largest in Australia), simplified structure (Australia and Canada), proprietary technology and good Balance Sheet.

Bell Potter has a buy rating and 63 cents price target on its shares. Based on its current share price of 50.5 cents, this implies potential upside of 25% for investors over the next 12 months.

PYC Therapeutics Ltd (ASX: PYC)

Another ASX penny stock to look at according to Bell Potter is PYC Therapeutics. It is clinical-stage biotechnology company developing multiple drug candidates for rare inherited diseases.

The broker highlights that PYC recently reported highly encouraging first clinical data for its lead drug candidate, VP-001, in patients with a rare form of blinding eye disease. It feels that the positive readout provides significant validation for the individual asset and broader PYC platform. It also feels that successful readouts in other phase 1/2 trials would provide considerable de-risking.

In light of this, this month Bell Potter initiated coverage on the ASX penny stock with a speculative buy rating and 17 cents price target. This implies potential upside of 70% for investors from current levels. The broker commented:

We initiate coverage of PYC with a speculative BUY recommendation and $0.17 valuation. Pro-forma cash balance was ~$84m as at 31 March 2024, providing runway into 2H CY25 to achieve the above-mentioned Phase 1/2 clinical trial readouts. PYC have multiple shots on goal with three highly promising drug candidates for rare diseases. We also see value in the company's internal platform and potential to continually generate differentiated RNA therapeutics for inherited diseases.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended PointsBet. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Small Cap Shares

A couple stares at the tv in shock, one holding the remote up ready to press.
Small Cap Shares

Analysts name 3 small cap ASX shares to buy for big returns

They may be small but they could deliver big returns over the next 12 months.

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Small Cap Shares

Why these small cap ASX shares could rise 85%+

Analysts at Morgans think these small caps are top options right now with big potential returns. But why?

Read more »

A woman wearing glasses and a black top smiles broadly as she stares at a money yarn full of coins representing the rising JB Hi-Fi share price and rising dividends over the past five years
Small Cap Shares

Analysts say these small cap ASX shares can deliver big returns

Analysts think these small caps are top options right now. But why?

Read more »

a woman holds a facebook like thumbs up sign high above her head. She has a very happy smile on her face.
Small Cap Shares

Morgans names the best small cap ASX shares to buy in May

The broker has these small caps on its best ideas list this month.

Read more »

Kid putting a coin in a piggy bank.
Small Cap Shares

Is it time to start buying up ASX small-cap shares?

Can small-caps deliver big returns? One fund manager has the answer.

Read more »

Kid stacking coins from the jar.
Small Cap Shares

1 ASX penny stock to buy in May while it is still only 47 cents

Bell Potter believes big returns could be on offer from this small cap.

Read more »

Two young boys with tennis racquets and wearing caps shake hands over a tennis ten on a tennie court.
Small Cap Shares

2 ASX small-cap shares with excellent potential I'd buy right now

I think these two ASX online technology-related stocks have excellent growth potential.

Read more »

A woman wearing glasses and a black top smiles broadly as she stares at a money yarn full of coins representing the rising JB Hi-Fi share price and rising dividends over the past five years
Small Cap Shares

Morgans rates these ASX small-cap shares as best buys

Big returns could be on the cards for buyers of these small caps according to the broker.

Read more »